NCT03236168View on ClinicalTrials.gov

Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands

PHASE3CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

February 28, 2018

Conditions
ScabiesHead Lice
Interventions
DRUG

Ivermectin

A single weight based dose of ivermectin

DRUG

Permethrin 5%

Permethrin cream is used in conjunction with Malathion shampoo when ivermectin is contra-indicated

DRUG

Malathion Shampoo 0.5%

Permethrin cream is used in conjunction with Malathion shampoo when ivermectin is contra-indicated

Trial Locations (1)

Unknown

Atoifi Adventist Hospital, Atoifi

All Listed Sponsors
lead

London School of Hygiene and Tropical Medicine

OTHER

NCT03236168 - Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands | Biotech Hunter | Biotech Hunter